Published in J Chromatogr on January 21, 1976
Interictal acute psychoses in temporal lobe epilepsy during withdrawal of anticonvulsant therapy. J Neurol Neurosurg Psychiatry (1979) 0.76
N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia (1975) 1.54
Delayed absorption of phenylbutazone caused by desmethylimipramine in humans. Eur J Pharmacol (1970) 1.47
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl (1975) 1.46
Zolpidem side-effects. Lancet (1993) 1.37
A sensitive gas chromatographic method for the determination of propranolol in human plasma. J Chromatogr (1973) 1.34
Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent. J Chromatogr (1979) 1.30
Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet (1981) 1.29
Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychol Med (2000) 1.26
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25
Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus. Eur J Clin Pharmacol (1980) 1.23
Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat. Biochem Pharmacol (1972) 1.18
Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Ann N Y Acad Sci (1971) 1.16
Metabolism and Pharmacolinetics of Carbamazepine. Drug Metab Rev (1975) 1.15
Diazepam elimination in premature and full term infants, and children. J Perinat Med (1973) 1.15
Pharmacokinetics of nomifensine in man. Psychopharmacologia (1975) 1.12
Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol (1986) 1.08
Clincial pharmacokinetics in neonates. Clin Pharmacokinet (1976) 1.07
Prevalence of nightmares and their relationship to psychopathology and daytime functioning in insomnia subjects. Sleep (1997) 1.06
Monosodium glutamate and the Chinese restaurant syndrome. Nature (1970) 1.02
Simple sensitive and specific gas chromatographic method for the quantification of diltiazem human body fluids. J Chromatogr (1977) 1.01
Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect. Br J Clin Pharmacol (1976) 1.01
Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia (1988) 1.01
Rapid and sensitive method for determination of haloperidol in human samples using nitrogen-phosphorus selective detection. J Chromatogr (1978) 0.99
Biochemical aspects of Huntington's chorea. J Neurol Neurosurg Psychiatry (1977) 0.97
Studies on plasma protein binding of carbamazepine. Pharmacol Res Commun (1974) 0.97
Pharmacokinetics of amiodarone in rats. J Cardiovasc Pharmacol (1982) 0.97
Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients. Epilepsia (1975) 0.95
Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects. Neurology (1976) 0.95
EEG profile of intravenous zolpidem in healthy volunteers. Psychopharmacology (Berl) (1994) 0.95
Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration. Br J Clin Pharmacol (1980) 0.94
Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies. Eur J Clin Pharmacol (1996) 0.93
Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary results. J Neurol Neurosurg Psychiatry (1975) 0.93
Clinical pharmacokinetics of antiepileptic drugs in adults. Pharmacol Ther (1980) 0.91
Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem. Drug Metab Rev (1992) 0.91
Evaluation of memory function in a population of epileptic patients and matched controls. Acta Neurol Scand Suppl (1980) 0.91
A gas chromatographic method for the determination of amantadine in human plasma. J Chromatogr (1972) 0.91
The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice. J Int Med Res (1992) 0.90
Carbamazepine: absorption, distribution, and excretion. Adv Neurol (1975) 0.90
Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects. Br J Clin Pharmacol (1992) 0.90
Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. II. Ventricular csf concentrations in acute brain post-traumatic syndromes. Eur Neurol (1975) 0.89
Determination of progabide and its main acid metabolite in biological fluids using high-performance liquid chromatography and electrochemical detection. Application to the measurement of blood/plasma partition ratio. J Chromatogr (1984) 0.89
Effect of thymoleptics on fenfluramine-induced depletion of brain serotonin in rats. Eur J Pharmacol (1973) 0.89
Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine. Ann Allergy (1992) 0.89
Double-blind crossover trial of progabide versus placebo in severe epilepsies. Epilepsia (1983) 0.88
Infants born to hypertensive mothers treated by acebutolol. Pharmacological studies in the perinatal period. Dev Pharmacol Ther (1982) 0.88
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra. J Pharmacol Exp Ther (1982) 0.88
Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine. Br J Clin Pharmacol (1985) 0.87
Long-term monitoring of tricyclic antidepressant plasma concentrations. Br J Psychiatry (1980) 0.87
A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia. Eur J Clin Pharmacol (1981) 0.87
Beta-blockade and blood-levels after low-dose oral propranolol: The hepatic "first-pass" threshold revisited. Lancet (1978) 0.86
Initiation of and adherence to treatment for mental disorders: examination of patient advocate group members in 11 countries. Med Care (2000) 0.86
Plasma protein binding of zolpidem in liver and renal insufficiency. Int J Clin Pharmacol Ther Toxicol (1988) 0.86
The gabaergic hypothesis of depression. Prog Neuropsychopharmacol Biol Psychiatry (1989) 0.85
Pharmacokinetics of amiodarone in man. J Cardiovasc Pharmacol (1982) 0.85
Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients. Clin Pharmacokinet (1983) 0.85
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials. Pharmacol Biochem Behav (1983) 0.85
Pharmacokinetics of propranolol in normal healthy volunteers. J Pharmacokinet Biopharm (1977) 0.85
Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man. Br J Clin Pharmacol (1980) 0.84
The effect of injections of fluorocitrate into the brains of rats. Biochem Pharmacol (1968) 0.84
Carbamazepine: biotransformation. Adv Neurol (1975) 0.84
Concentrations of desipramine in the vas deferens and potentiation of noradrenaline response. Br J Pharmacol (1971) 0.83
Carbamazepine/valproic acid interaction in man and rhesus monkey. Epilepsia (1984) 0.83
Placental transfer to diazepam and its disposition in the newborn. Clin Pharmacol Ther (1975) 0.83
Clinical relevance of pharmacokinetics. Clin Pharmacokinet (1980) 0.83
Metabolism of exogenous cortisol in humans. I. Diurnal variation in plasma disappearance rate. Biochem Pharmacol (1970) 0.83
Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers. Br J Clin Pharmacol (1980) 0.83
Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine. Acta Psychiatr Scand (1990) 0.83
EEG profile of litoxetine after single and repeated administration in healthy volunteers. Br J Clin Pharmacol (1994) 0.82
A double blind study on the effects of monosodium glutamate in man. Biomedicine (1973) 0.82
Carbamazepine and carbamazepine-10, 11-epoxide concentrations in human brain. Br J Clin Pharmacol (1977) 0.82
Learning impairment in epileptic patients. Epilepsia (1983) 0.82
Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocker SL 75212 in healthy volunteers [proceedings]. Br J Clin Pharmacol (1979) 0.82
Pharmacokinetics of diltiazem after intravenous and oral administration. Eur J Clin Pharmacol (1983) 0.82
GABA and affective disorders. Med Biol (1987) 0.82
Effects of piribedil on noradrenaline and MOPEG-SO4 levels in the rat brain. Eur J Pharmacol (1974) 0.81
Meal-dependent absorption of enteric-coated sodium valproate. Epilepsia (1980) 0.81
Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderly. Psychopharmacology (Berl) (1980) 0.81
High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study. Arch Gen Psychiatry (1982) 0.81
Relationships between chronotropic effect, 1-3H-noradrenaline uptake and tissue concentrations of desipramine, protripyline and doxepin in rat isolated atria. Arch Int Pharmacodyn Ther (1976) 0.80
Plasma concentrations and cardiotoxic effects of desipramine and protriptyline in the rat. Br J Pharmacol (1977) 0.80
Carbamazepine plasma and tissue levels in the rat. Biochem Pharmacol (1971) 0.80
Placental transfer of pethidine and norpethidine and their pharmacokinetics in the newborn. Eur J Clin Pharmacol (1980) 0.80
Brain distribution of propranolol in the rat. Eur J Pharmacol (1979) 0.80
Pharmacokinetics of indomethacin in the premature infant. Dev Pharmacol Ther (1980) 0.80
Gas chromatographic-mass spectrometric studies on carbamazepine. Adv Biochem Psychopharmacol (1973) 0.80
Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat. J Pharmacol Exp Ther (1989) 0.80
The enzymatic systems involved in the mammalian metabolism of methylamine. Gen Pharmacol (1985) 0.80
CSF concentrations and serum protein binding of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients. Br J Clin Pharmacol (1976) 0.80
Pharmacokinetics and metabolism of diltiazem in man. Acta Cardiol (1980) 0.80
Blood pressure decrease and responsiveness to renin-releasing stimuli under increasing doses of propranolol in patients with essential hypertension. Clin Sci Mol Med Suppl (1975) 0.80
Effect of anticholinergic drugs on gastro-intestinal absorption of L-dopa in rats and in man. Eur J Pharmacol (1976) 0.79
Uptake of desipramine by the rat vas deferens. Br J Pharmacol (1972) 0.79
A method for the determination of imipramine in human plasma by gas-liquid chromatography-mass fragmentography. J Chromatogr (1972) 0.79
Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients. Pharmacopsychiatry (1994) 0.79